José N Nobrega Selected Research

beta-carboline-3-carboxylic acid methyl ester

1/2010

Inverse benzodiazepine agonist beta-CCM does not reverse learning deficit induced by sleep deprivation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José N Nobrega Research Topics

Disease

10	Catalepsy 12/2014 - 09/2005
7	Tardive Dyskinesia 01/2017 - 05/2002
6	Sleep Deprivation 01/2011 - 07/2003
5	Treatment-Resistant Depressive Disorder 01/2016 - 06/2014
5	Schizophrenia (Dementia Praecox) 07/2015 - 02/2007
4	Anhedonia 08/2021 - 02/2009
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020 - 02/2015
4	Movement Disorders (Movement Disorder) 01/2017 - 05/2002
4	Dystonia (Limb Dystonia) 01/2017 - 07/2006
4	Dyskinesias (Dyskinesia) 08/2014 - 08/2010
3	Substance-Related Disorders (Drug Abuse) 01/2020 - 04/2005
3	Parkinson Disease (Parkinson's Disease) 01/2015 - 07/2012
2	Gambling (Pathological Gambling) 01/2020 - 05/2013
2	Cognitive Dysfunction 07/2017 - 04/2011
2	Mood Disorders (Mood Disorder) 01/2014 - 04/2011
2	Epilepsy (Aura) 01/2014 - 01/2014
1	Depressive Disorder (Melancholia) 01/2022
1	Obesity 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	AIDS-Related Complex (ARC) 03/2016
1	Seasonal Affective Disorder 01/2016
1	Seizures (Absence Seizure) 01/2014
1	Mental Disorders (Mental Disorder) 03/2013
1	Alzheimer Disease (Alzheimer's Disease) 04/2011
1	Memory Disorders (Memory Loss) 04/2011
1	Psychotic Disorders (Schizoaffective Disorder) 08/2008
1	Neurobehavioral Manifestations 08/2008
1	Pain (Aches) 03/2007
1	Hypersensitivity (Allergy) 03/2007
1	Avitaminosis (Vitamin Deficiency) 10/2006
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2006

Drug/Important Bio-Agent (IBA)

9	Antipsychotic Agents (Antipsychotics)IBA 01/2017 - 05/2002
6	Haloperidol (Haldol)FDA LinkGeneric 01/2017 - 08/2006
5	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 05/2002
5	Cholinergic Agents (Cholinergics)IBA 01/2017 - 07/2003
5	Serotonin (5 Hydroxytryptamine)IBA 01/2014 - 02/2005
4	Amphetamine (Amfetamine)FDA LinkGeneric 10/2011 - 07/2007
4	ProlactinIBA 10/2008 - 09/2005
3	Peptides (Polypeptides)IBA 12/2015 - 12/2014
3	Pharmaceutical PreparationsIBA 07/2007 - 02/2005
2	Sucrose (Saccharose)IBA 08/2021 - 02/2009
2	EndocannabinoidsIBA 01/2020 - 01/2020
2	Cholinergic Antagonists (Anticholinergics)IBA 07/2017 - 01/2017
2	AntioxidantsIBA 01/2017 - 06/2014
2	Proteins (Proteins, Gene)FDA Link 03/2016 - 12/2014
2	A-factor (Streptomyces)IBA 03/2016 - 07/2015
2	Antidepressive Agents (Antidepressants)IBA 12/2015 - 02/2005
2	cupric sulfide (CuS)IBA 12/2015 - 01/2014
2	Opioid Analgesics (Opioids)IBA 07/2015 - 03/2007
2	Therapeutic UsesIBA 08/2014 - 10/2011
2	Aripiprazole (Abilify)FDA Link 10/2011 - 09/2006
2	BenzodiazepinesIBA 01/2010 - 03/2005
2	Phencyclidine (Angel Dust)IBA 10/2008 - 08/2008
2	Risperidone (Risperdal Consta)FDA LinkGeneric 10/2008 - 09/2006
1	PotassiumIBA 01/2022
1	CalciumIBA 01/2022
1	Tropicamide FDA LinkGeneric 01/2017
1	Thioctic Acid (Lipoic Acid)IBA 01/2017
1	Trihexyphenidyl (Artane)FDA LinkGeneric 01/2017
1	Ethanol (Ethyl Alcohol)IBA 03/2016
1	Potassium Channels (Potassium Channel)IBA 01/2016
1	N- (6- Chloropyridin- 3- yl)- 3,4- difluorobenzamideIBA 01/2016
1	ezogabine (retigabine)IBA 01/2016
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2016
1	Anti-Anxiety Agents (Anxiolytics)IBA 12/2015
1	Glutens (Glutelin)IBA 07/2015
1	Caseins (Casein)FDA Link 07/2015
1	CorticosteroneIBA 02/2015
1	Glycogen Synthase KinasesIBA 12/2014
1	Capsules (Microcapsules)IBA 11/2014
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2014
1	PlacebosIBA 01/2014
1	salicylhydroxamic acid (SHAM)IBA 01/2014
1	AutoreceptorsIBA 01/2014
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 10/2011
1	KetanserinIBA 06/2011
1	Amyloid (Amyloid Fibrils)IBA 04/2011
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2011
1	Dizocilpine Maleate (Dizocilpine)IBA 01/2011
1	(5,6-dimethoxyindan-2-yl)dipropylamineIBA 08/2010
1	beta-carboline-3-carboxylic acid methyl esterIBA 01/2010
1	Amisulpride (Solian)IBA 10/2008
1	Clozapine (Clozaril)FDA LinkGeneric 10/2008
1	stepholidineIBA 08/2008
1	Morphine (MS Contin)FDA LinkGeneric 03/2007
1	mu Opioid Receptors (mu Opioid Receptor)IBA 03/2007
1	Methylazoxymethanol AcetateIBA 02/2007
1	HomocysteineIBA 10/2006
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2006
1	Cholinergic ReceptorsIBA 07/2006
1	Loxapine (Loxitane)FDA LinkGeneric 09/2005
1	Messenger RNA (mRNA)IBA 05/2005
1	OrexinsIBA 05/2005
1	MuscimolIBA 03/2005
1	Flunitrazepam (Rohypnol)IBA 03/2005
1	gamma-Aminobutyric Acid (GABA)IBA 03/2005
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2005

Therapy/Procedure

15	Deep Brain Stimulation 01/2018 - 05/2011
3	Therapeutics 11/2016 - 01/2014
1	Preoperative Period 01/2014